Simulating the antimicrobial mechanism of human β-defensin-3 with coarse-grained molecular dynamics

Journal of Biomolecular Structure and Dynamics

Volumn 33, Issue 11, 2015, Pages 2522-2529

  Zhao, Xi ^a   Yu, Hui ^b   Yang, Liu ^a   Li, Qianqian ^a   Huang, Xuri ^a  

^a JILIN UNIVERSITY   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

antimicrobial mechanism; coarse grained; human defensin 3; molecular dynamics

Indexed keywords

ANTIINFECTIVE AGENT; BETA DEFENSIN 3; LIPID; OLIGOMER; PHOSPHATIDYLCHOLINE; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; BETA-DEFENSIN 3, HUMAN; LIPID BILAYER; PROTEIN BINDING;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BIOPHYSICS; CONTROLLED STUDY; DRUG GRANULE; DRUG MECHANISM; MOLECULAR DYNAMICS; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SIMULATION; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; LIPID BILAYER; METABOLISM; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; HUMANS; LIPID BILAYERS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84942991990     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2014.1002424     Document Type: Article

References (45)

1. Arouri, A., Dathe, M., & Blume, A. (2009). Peptide induced demixing in PG/PE lipid mixtures: A mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochimica et Biophysica Acta, 1788, 650-659.
2. Baaden, M., & Marrink, S. J. (2013). Coarse-grain modelling of protein-protein interactions. Current Opinion in Structural Biology, 23, 878-886.
3. Barnound, J., & Monticelli, L. (2015). Coarse-grained force fields for molecular simulations. In A. Kukol (Ed.), Molecular modeling of proteins (Part I, Vol. 1215, pp. 125-149). New York, NY: Springer.
4. Boman, H. G. (1995). Peptide antibiotics and their role in innate immunity. Annual Review of Immunology, 13, 61-92.
5. Boniotto, M., Antcheva, N., Zelezetsky, I., Tossi, A., Palumbo, V., Verga Falzacappa, M. V., ⋯ Crovella, S. (2003). A study of host defence peptide β-defensin 3 in primates. Biochemical Journal, 374, 707-714.
6. Castillo, N., Monticelli, L., Barnoud, J., & Tieleman, D. P. (2013). Free energy of WALP23 dimer association in DMPC, DPPC, and DOPC bilayers. Chemistry and Physics of Lipids, 169, 95-105.
7. Crovella, S., Antcheva, N., Zelezetsky, I., Boniotto, M., Pacor, S., Falzacappa, M. V. V., & Tossi, A. (2005). Primate β-defensins - Structure, function and evolution. Current Protein and Peptide Science, 6, 7-21.
8. Epand, R. F., Maloy, L., Ramamoorthy, A., & Epand, R. M. (2010). Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline states in the presence of phosphatidylglycerol: Lipid clustering in anionic membranes. Biophysical Journal, 98, 2564-2573.
9. García, J. R. C., Jaumann, F., Schulz, S., Krause, A., Rodríguez-Jiménez, F. J., Forssmann, U., ⋯ Bals, R. (2001). Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell and Tissue Research, 306, 257-264.
10. Harder, J., Bartels, J., Christophers, E., & Schroder, J. M. (2001). Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. Journal of Biological Chemistry, 276, 5707-5713.
11. Heller, H., Schaefer, M., & Schulten, K. (1993). Molecular dynamics simulation of a bilayer of 200 lipids in the gel and in the liquid crystal phase. The Journal of Physical Chemistry, 97, 8343-8360.
12. Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008). GROMACS 4: algorithms for highly efficient, loadbalanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435-447.
13. Hill, C. P., Yee, J., Selsted, M. E., & Eisenberg, D. (1991). Crystal structure of defensin HNP-3, an amphiphilic dimer: Mechanisms of membrane permeabilization. Science, 251, 1481-1485.
14. Hoover, W. G. (1985). Canonical dynamics: Equilibrium phasespace distributions. Physical Review A, 31, 1695-1697.
15. Hoover, D. M., Chertov, O., & Lubkowski, J. (2001). The structure of human β-defensin-1: New insights into structural properties of β-defensins. Journal of Biological Chemistry, 276, 39021-39026.
16. Hoover, D. M., Rajashankar, K. R., Blumenthal, R., Puri, A., Oppenheim, J. J., Chertov, O., & Lubkowski, J. (2000). The structure of human β-defensin-2 shows evidence of higher order oligomerization. Journal of Biological Chemistry, 275, 32911-32918.
17. Hoover, D. M., Wu, Z., Tucker, K., Lu, W., & Lubkowski, J. (2003). Antimicrobial characterization of human β-defensin 3 derivatives. Antimicrobial Agents and Chemotherapy, 47, 2804-2809.
18. Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33-38.
19. Jean-Francois, F., Castano, S., Desbat, B., Odaert, B., Roux, M., Metz-Boutigue, M. H., & Dufourc, E. J. (2008). Aggregation of cateslytin beta-sheets on negatively charged lipids promotes rigid membrane domains. A new mode of action for antimicrobial peptides? Biochemistry, 47, 6394-6402.
20. Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006). Peptide antimicrobial agents. Clinical Microbiology Reviews, 19, 491-511.
21. Jia, H. P., Schutte, B. C., Schudye, A., Linzmeier, R., Guthmiller, J. M., Johnson, G. K., ⋯ McCray Jr., P. B. (2001). Discovery of new human β-defensins using a genomics-based approach. Gene, 263, 211-218.
22. Klüver, E., Schulz-Maronde, S., Scheid, S., Meyer, B., Forssmann, W. G., & Adermann, K. (2005). Structure-Activity relation of human β-defensin 3: Influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry, 44, 9804-9816.
23. Koczulla, A. R., & Bals, R. (2003). Antimicrobial peptides. Drugs, 63, 389-406.
24. Lindahl, E., & Sansom, M. S. (2008). Membrane proteins: Molecular dynamics simulations. Current Opinion in Structural Biology, 18, 425-431.
25. Marrink, S. J., Risselada, H. J., Yefimov, S., Tieleman, D. P., & de Vries, A. H. (2007). The Martini force field: Coarse grained model for biomolecular simulations. The Journal of Physical Chemistry B, 111, 7812-7824.
26. Mátyus, E., Kandt, C., & Tieleman, D. P. (2007). Computer simulation of antimicrobial peptides. Current Medicinal Chemistry, 14, 2789-2798.
27. Monticelli, L., Kandasamy, S. K., Periole, X., Larson, R. G., Tieleman, D. P., & Marrink, S. J. (2008). The Martini coarse-grained force field: extension to proteins. Journal of Chemical Theory and Computation, 4, 819-834.
28. Murzyn, K., & Pasenkiewicz-Gierula, M. (1999). Construction and optimization of a computer model for a bacterial membrane. Acta Biochimica Polonica, 46, 631-639.
29. Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., ⋯ Kristensen, H. H. (2005). Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature, 437, 975-980.
30. Nose, S., & Klein, M. L. (1983). Constant pressure molecular dynamics for molecular systems. Molecular Physics, 50, 1055-1076.
31. Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52, 7182-7190.
32. Pastor, R. W., & Feller, S. E. (1996). Time scales of lipid dynamics and molecular dynamics. In: K. M. Merz Jr. B. Roux (Eds.), Biological membranes: A molecular perspective from computation and experiment (pp. 3-30). Boston, MA: Birkhauser.
33. Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007). Improved antimicrobial peptides based on acyl-lysine oligomers. Nature Biotechnology, 25, 657-659.
34. Rotem, S., Radzishevsky, I. S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2008). Analogous oligo-acyllysines with distinct antibacterial mechanisms. The FASEB Journal, 22, 2652-2661.
35. Sawai, M. V., Jia, H. P., Liu, L., Aseyev, V., Wiencek, J. M., McCray, P. B., Jr., ⋯ Tack, B. F. (2001). The NMR structure of human β-defensin-2 reveals a novel R-helical segment. Biochemistry, 40, 3810-3816.
36. Schibli, D. J., Hunter, H. N., Aseyev, V., Starner, T. D., Wiencek, J. M., McCray, P. B., Jr., ⋯ Vogel, H. J. (2002). The solution structures of the human β-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. Journal of Biological Chemistry, 277, 8279-8289.
37. Schutte, B. C., Mitros, J. P., Bartlett, J. A., Walters, J. D., Jia, H. P., Welsh, M. J., ⋯ McCray Jr., P.B. (2002). Discovery of five conserved β-defensin gene clusters using a computational search strategy. Proceedings of the National Academy of Sciences, 99, 2129-2133.
38. Shai, Y. (1999). Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochimica et Biophysica Acta, 1462, 55-70.
39. Shelburne, C. E., Coulter, W. A., Olguin, D. A., Lantz, M. S., & Lopatin, D. E. (2005). Induction of β-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrobial Agents and Chemotherapy, 49, 183-187.
40. Starner, T. D., Agerberth, B., Gudmundsson, G. H., & McCray, P. B., Jr (2005). Expression and activity of β-defensins and LL-37 in the developing human lung. The Journal of Immunology, 174, 1608-1615.
41. Uran, S., Larsen, A., Jacobsen, P. B., & Skotland, T. (2001). Analysis of phospholipid species in human blood using normal-phase liquid chromatography coupled with electrospray ionization ion-trap tandem mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications, 758, 265-275.
42. van der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701-1718.
43. Wang, Z., & Wang, G. (2004). APD: The antimicrobial peptide database. Nucleic Acids Research, 32, 590D-592.
44. Wu, Z., Hoover, D. M., Yang, D., Boulegue, C., Santamaria, F., Oppenheim, J. J., ⋯ Lu, W. (2003). Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3. Proceedings of the National Academy of Sciences, 100, 8880-8885.
45. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature, 415, 389-395.